pilipiliĀž»­

 

Hark! A hidden hearing aid

pilipiliĀž»­ invention licensed by Ototronix

- July 26, 2012

Rob Adamson shows off a prototype of his team's new hearing aid device. (Bruce Bottomley)
Rob Adamson shows off a prototype of his team's new hearing aid device. (Bruce Bottomley)

Conspicuous hearing aids may soon be a thing of the past thanks to a new device developed by three Dalhousie faculty members.

For the past several years, Manohar Bance, professor and acting head of the Faculty of Medicineā€™s otolaryngology division, and two assistant professors in the School of Biomedical Engineering, Jeremy Brown and Rob Adamson, have been developing a new hearing aid implant that will be invisible to the naked eye.

Last week, it was announced that Dal has signed an exclusive worldwide licensing agreement for the hearing aid technology with U.S. medical device company Ototronix.

ā€œIā€™m excited and apprehensive,ā€ says Dr. Bance. He calls the licensing agreement ā€œthe starting point. We have a lot of work ahead of us. It takes about two years just to get basic trials done.ā€

Dr. Bance is a surgeon and says he is mostly involved in the ā€œclinical sideā€ of things. ā€œMy role in this has been mostly surgical and clinical: figuring out how big the device will be, how we can implant it, what are the challenges of implantation, what patient population weā€™re targeting, how patients can benefit.ā€

ā€œFeels like part of your bodyā€


The device that Drs. Bance, Brown and Adamson have developed is designed for patients suffering from ear damage and unilateral (one-sided) hearing loss. It differs from traditional cochlear implants, which are implanted in the middle ear, by being implanted directly on the skull.

ā€œ[The] skin heals over it, so it's basically invisible once it's been implantedā€ says Dr. Adamson. ā€œInstead of sticking something in your ear that you're constantly wearing, an implanted hearing aid is something that feels like part of your bodyā€¦from a patient's point of view, this is a great thing because it just becomes a part of them and they don't have to think about it anymore."

MIchael Spearman, CEO of Ototronix, says that inconspicuousness will play a big part in the deviceā€™s appeal.

ā€œOnly a fourth of the people who need hearing aids wear them,ā€ he says. ā€œA lot of the products currently on the market use a titanium abutment...basically a screw that goes into the head. Somebody takes it off, they look like Frankenstein; there's a little peg sticking out. With this, it's totally invisible when the person isn't wearing their hearing aid device. It's very discrete, gives better efficacy, and better cosmetics."

The project also miniaturizes the power source for the hearing aid. ā€œThe things that have traditionally powered hearing aids are much bigger than the hearing aids themselves,ā€ says Dr. Adamson. ā€œThe goal here is to make something innocuous and invisible and power systems have to be included as well.ā€

Success through partnership


Bringing their device to the commercial market required a partnership with a company like Ototronix. Luckily, Mr. Spearman was in attendance at a conference at which Dr. Brown gave the keynote address.

ā€œIt was interesting when Jeremy was giving his talk,ā€ he says. ā€œ[We] said, ā€˜This is different.ā€™ We knew these guys were on to something and had unique technology and, to us, if weā€™re going to be bringing new technology to the market, itā€™s got to be different. It canā€™t be the same old stuff.ā€

ā€œThese [Ototronix] guys are absolute experts in the stuff thatā€™s hard for academics ā€“ the marketing and distribution of devices,ā€ says Dr. Adamson. ā€œTheyā€™ve proven they can bring implanted hearing aids to the market pilipiliĀž»­fully and they sit at a place in the system where theyā€™re in constant contact with clinicians all over the world. Theyā€™ve really helped us so far in the device trial tests and Iā€™m sure theyā€™ll continue to help us over the next several years.ā€

Stephen Hartlen, Dalhousieā€™s assistant vice-president of industry relations, says the license is just the beginning. ā€œWe have great confidence in Ototronix and know theyā€™ll be very pilipiliĀž»­ful in marketing this world-class innovation created right here at pilipiliĀž»­ and Capital Health,ā€ he says

Those sentiments are echoed by Raymond LeBlanc, vice-president of learning, research and innovation at Capital Health: ā€œWe look forward to many repetitions (of this), much more DNA that shows what can happen as a result of the interdisciplinary partnerships between the Faculties of Medicine and Engineering and Dalhousieā€™s Industry Liaison and Innovation and Biomedical Engineering departments.ā€

ā€œItā€™s really quite a big project when you think of all the parts that had to come together,ā€ says Dr. Adamson. ā€œI donā€™t think thereā€™s a better place in the world to be doing this than Dalhousie.ā€